Evidence map›Paper›PMID 28213858›Full record

ReviewCurrent urology reports2017

Dysfunctional Voiders-Medication Versus Urotherapy?

Angela M Arlen

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05613153 (Peppermint Oil as an Alternative Treatment for Children With Bladder and Bowel Dysfunction), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05613153 naenrolling by invitationnot on this mapstarted 2022, after this paper: background citation

Peppermint Oil as an Alternative Treatment for Children With Bladder and Bowel Dysfunction: A Prospective Study

TypeinterventionalSponsorChildren's Hospital of Orange CountyRan2022 to 2026Enrolled30ConditionsBladder and Bowel DysfunctionArmsPeppermint Oil
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Angela M ArlenDepartment of Urology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 3RCP, Iowa City, IA, 52242-1089, USA. angela-arlen@uiowa.edu.
University of Iowa Hospitals and Clinics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDysfunctional voiding is defined as "habitual contraction of the urethral sphincter during voiding." Children with dysfunctional voiding remain a challenge, and the approach to and management of LUT dysfunction varies widely among programs and providers with the role of pharmacotherapy being ill defined. RECENT

findingsAnimated biofeedback is the current treatment modality of choice in children who are not responsive to standard urotherapy. Comprehensive biofeedback programs incorporate continued elimination education, voiding diaries, and home exercises with high success rates. Recent studies suggest botulinum toxin A results in persistent satisfactory results in select children with refractory dysfunctional voiding. Conservative measures including an aggressive bowel regimen and timed voiding are the mainstays of treatment, and motivated children with persistent symptoms often respond favorably to escalating urotherapy with biofeedback. Pharmacotherapy plays an ancillary role in the management of dysfunctional voiding.

Indexed as

Adrenergic alpha-AntagonistsBiofeedback, PsychologyBotulinum Toxins, Type ACholinergic AntagonistsExercise TherapyHumansUrinary Bladder DiseasesAdrenergic alpha-AntagonistsBotulinum Toxins, Type ACholinergic AntagonistsBladder-bowel dysfunction (BBD)Dysfunctional voidingLower urinary tract symptoms (LUTS)PediatricUrotherapy

Identifiers

PMID28213858
OpenAlexW2589057576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.